Impaired bioavailability and antiplatelet effect of high-dose clopidogrel in patients after cardiopulmonary resuscitation (CPR).
about
Platelet aggregation and clot formation in comatose survivors of cardiac arrest treated with induced hypothermia and dual platelet inhibition with aspirin and ticagrelor; a prospective observational studyACS network-based implementation of therapeutic hypothermia for the treatment of comatose out-of-hospital cardiac arrest survivors improves clinical outcomes: the first European experience.Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.Optimizing the Use of Cangrelor in the Real World.Role of New Antiplatelet Drugs on Cardiovascular Disease: Update on Cangrelor.Out-of-hospital cardiac arrest: contemporary management and future perspectives.Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated with mild therapeutic hypothermia after cardiac arrest due to acute myocardial infarction.Routine pretreatment with abciximab versus standard periprocedural therapy in mechanically ventilated cardiogenic shock patients undergoing primary percutaneous coronary intervention: Subanalysis of the PRAGUE-7 study.Clopidogrel does not work following cardiopulmonary resuscitation.Pharmacosimulation of interruptions and its solution in intravenous administration of cangrelor.Erythropoietin therapy after out-of-hospital cardiac arrest: A systematic review and meta-analysis.Clopidogrel in Critically Ill Patients.The Implementation of Targeted Temperature Management: An Evidence-Based Guideline from the Neurocritical Care Society.
P2860
Q34325757-4D5EA784-8A36-47AE-9FD8-EE424DE894D8Q36734920-70D2152A-B059-4C9D-BB03-260824504BAAQ38547727-81215D22-6B33-4AAD-BA0C-50F37687F18AQ38817125-F2A94E05-014B-4127-8BFF-AC604C10D71AQ38974706-CBDB6616-BEE0-4FCA-A6CC-EC035C5C9898Q38980590-97909DC3-1ECC-4C98-88CC-8C6F978983ADQ40572790-8BF1D55D-5454-4BA3-BCDE-E8E6BCC0CD13Q41834772-3DA9A0C1-D1D9-4A9D-9423-86BD38E254E7Q45214679-3064EF8C-2CA1-4962-96F3-4BD10B206A3EQ47646996-94C79F89-2BFA-4DAF-A312-208285C40621Q47873221-3C06ECFD-F770-4FCE-8DA8-D2269F35850BQ47980408-966CDC11-E10E-4E97-82D3-A0C830301263Q48015342-9CC84446-094B-442E-932E-1B4C0F689C9E
P2860
Impaired bioavailability and antiplatelet effect of high-dose clopidogrel in patients after cardiopulmonary resuscitation (CPR).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Impaired bioavailability and a ...... pulmonary resuscitation (CPR).
@en
Impaired bioavailability and a ...... cardiopulmonary resuscitation
@nl
type
label
Impaired bioavailability and a ...... pulmonary resuscitation (CPR).
@en
Impaired bioavailability and a ...... cardiopulmonary resuscitation
@nl
prefLabel
Impaired bioavailability and a ...... pulmonary resuscitation (CPR).
@en
Impaired bioavailability and a ...... cardiopulmonary resuscitation
@nl
P2093
P2860
P1476
Impaired bioavailability and a ...... pulmonary resuscitation (CPR).
@en
P2093
L Součková
O Hlinomaz
R Opatřilová
V Zvoníček
P2860
P2888
P304
P356
10.1007/S00228-012-1360-0
P577
2012-08-14T00:00:00Z
P6179
1019491634